Literature DB >> 33535185

A short deletion in the DNA-binding domain of STAT3 suppresses growth and progression of colon cancer cells.

Yi-Jia Xiong1, Dong-Yang Liu2, Rong-Rong Shen3, Yong Xiong3.   

Abstract

In this study, we investigated the effect of a short deletion in the DNA-binding domain of STAT3 (STAT3del) on the transcriptional activation of STAT3 target genes and its relationship with colon carcinogenesis. We used the CRISPR-CAS9 gene editing system to delete a short sequence encoding amino acids 400-411 in the DNA-binding domain (amino acid sequence: 317-567) from STAT3 gene in SW480, SW620 and HCT116 colon cancer cells. ChIP sequencing analysis showed that STAT3del occupancy was significantly reduced in 1029 genes and significantly increased in 475 genes compared to wild-type STAT3. The mutation altered the DNA motifs recognized by STAT3del as compared to the wild-type STAT3. We observed a strong correlation between expression of the STAT3 target genes and the loss or gain of STAT3del binding to their promoters. CCK-8, wound healing, and TUNEL assays showed reduced proliferation, migration, and survival of SW480, SW620 and HCT-116 cells expressing STAT3del as compared to the corresponding controls. These findings demonstrate that a short deletion in the DNA-binding domain of STAT3 alters its genome-wide DNA-binding and transcriptional profile of STAT3-target proteins, and suppresses the growth, progression and survival of colon cancer cells.

Entities:  

Keywords:  JAK/STAT pathway; STAT3; colon cancer; gain of function

Year:  2021        PMID: 33535185      PMCID: PMC7950243          DOI: 10.18632/aging.202439

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  39 in total

Review 1.  Targeting the IL-6/JAK/STAT3 signalling axis in cancer.

Authors:  Daniel E Johnson; Rachel A O'Keefe; Jennifer R Grandis
Journal:  Nat Rev Clin Oncol       Date:  2018-02-06       Impact factor: 66.675

Review 2.  The molecular details of cytokine signaling via the JAK/STAT pathway.

Authors:  Rhiannon Morris; Nadia J Kershaw; Jeffrey J Babon
Journal:  Protein Sci       Date:  2018-12       Impact factor: 6.725

3.  Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.

Authors:  Jianjiong Gao; Bülent Arman Aksoy; Ugur Dogrusoz; Gideon Dresdner; Benjamin Gross; S Onur Sumer; Yichao Sun; Anders Jacobsen; Rileen Sinha; Erik Larsson; Ethan Cerami; Chris Sander; Nikolaus Schultz
Journal:  Sci Signal       Date:  2013-04-02       Impact factor: 8.192

4.  Molecular dynamics studies of the STAT3 homodimer:DNA complex: relationships between STAT3 mutations and protein-DNA recognition.

Authors:  Jarmila Husby; Alan K Todd; Shozeb M Haider; Giovanna Zinzalla; David E Thurston; Stephen Neidle
Journal:  J Chem Inf Model       Date:  2012-05-03       Impact factor: 4.956

Review 5.  STAT3: a multifaceted oncoprotein.

Authors:  Aleks C Guanizo; Chamira Dilanka Fernando; Daniel J Garama; Daniel J Gough
Journal:  Growth Factors       Date:  2018-06-06       Impact factor: 2.511

6.  The Cancer Genome Atlas Pan-Cancer analysis project.

Authors:  John N Weinstein; Eric A Collisson; Gordon B Mills; Kenna R Mills Shaw; Brad A Ozenberger; Kyle Ellrott; Ilya Shmulevich; Chris Sander; Joshua M Stuart
Journal:  Nat Genet       Date:  2013-10       Impact factor: 38.330

Review 7.  Targeting STEAP1 Protein in Human Cancer: Current Trends and Future Challenges.

Authors:  J Barroca-Ferreira; J P Pais; M M Santos; A M Goncalves; I M Gomes; I Sousa; S M Rocha; L A Passarinha; C J Maia
Journal:  Curr Cancer Drug Targets       Date:  2018       Impact factor: 3.428

8.  PD-L1 Is Upregulated by Simultaneous Amplification of the PD-L1 and JAK2 Genes in Non-Small Cell Lung Cancer.

Authors:  Seiichi Ikeda; Tatsuro Okamoto; Shinji Okano; Yuichiro Umemoto; Tetsuzo Tagawa; Yosuke Morodomi; Mikihiro Kohno; Shinichiro Shimamatsu; Hirokazu Kitahara; Yuzo Suzuki; Takatoshi Fujishita; Yoshihiko Maehara
Journal:  J Thorac Oncol       Date:  2016-01       Impact factor: 15.609

9.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.

Authors:  Ethan Cerami; Jianjiong Gao; Ugur Dogrusoz; Benjamin E Gross; Selcuk Onur Sumer; Bülent Arman Aksoy; Anders Jacobsen; Caitlin J Byrne; Michael L Heuer; Erik Larsson; Yevgeniy Antipin; Boris Reva; Arthur P Goldberg; Chris Sander; Nikolaus Schultz
Journal:  Cancer Discov       Date:  2012-05       Impact factor: 39.397

10.  Comprehensive meta-analysis of Signal Transducers and Activators of Transcription (STAT) genomic binding patterns discerns cell-specific cis-regulatory modules.

Authors:  Keunsoo Kang; Gertraud W Robinson; Lothar Hennighausen
Journal:  BMC Genomics       Date:  2013-01-16       Impact factor: 3.969

View more
  1 in total

1.  MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen.

Authors:  Richard E Kast; Alex Alfieri; Hazem I Assi; Terry C Burns; Ashraf M Elyamany; Maria Gonzalez-Cao; Georg Karpel-Massler; Christine Marosi; Michael E Salacz; Iacopo Sardi; Pieter Van Vlierberghe; Mohamed S Zaghloul; Marc-Eric Halatsch
Journal:  Cancers (Basel)       Date:  2022-05-23       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.